BELLUS Health Inc
TSX:BLU
BELLUS Health Inc
Revenue
BELLUS Health Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BELLUS Health Inc
TSX:BLU
|
Revenue
$15k
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-40%
|
|
Zymeworks Inc
NYSE:ZYME
|
Revenue
$76m
|
CAGR 3-Years
25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Revenue
$51.1m
|
CAGR 3-Years
700%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Revenue
$2.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Revenue
$175.5m
|
CAGR 3-Years
52%
|
CAGR 5-Years
223%
|
CAGR 10-Years
68%
|
|
Spectral Medical Inc
TSX:EDT
|
Revenue
CA$1.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-5%
|
See Also
What is BELLUS Health Inc's Revenue?
Revenue
15k
USD
Based on the financial report for Mar 31, 2023, BELLUS Health Inc's Revenue amounts to 15k USD.
What is BELLUS Health Inc's Revenue growth rate?
Revenue CAGR 10Y
-40%
Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for BELLUS Health Inc have been -21% over the past three years , -35% over the past five years , and -40% over the past ten years .